Quezada, M.J.; Picco, M.E.; Villanueva, M.B.; Castro, M.V.; Barbero, G.; Fernández, N.B.; Illescas, E.; Lopez-Bergami, P.
BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance. Cancers 2021, 13, 78.
https://doi.org/10.3390/cancers13010078
AMA Style
Quezada MJ, Picco ME, Villanueva MB, Castro MV, Barbero G, Fernández NB, Illescas E, Lopez-Bergami P.
BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance. Cancers. 2021; 13(1):78.
https://doi.org/10.3390/cancers13010078
Chicago/Turabian Style
Quezada, MarÃa Josefina, MarÃa Elisa Picco, MarÃa Belén Villanueva, MarÃa Victoria Castro, Gastón Barbero, Natalia Brenda Fernández, Edith Illescas, and Pablo Lopez-Bergami.
2021. "BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance" Cancers 13, no. 1: 78.
https://doi.org/10.3390/cancers13010078
APA Style
Quezada, M. J., Picco, M. E., Villanueva, M. B., Castro, M. V., Barbero, G., Fernández, N. B., Illescas, E., & Lopez-Bergami, P.
(2021). BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance. Cancers, 13(1), 78.
https://doi.org/10.3390/cancers13010078